Pfizer adds second Phase 3 berobenatide knee osteoarthritis trial, completes Phase 2b VESPER-3Nov 6Weekly roundup, 13 itemsberobenatidemarstacimab-hncqUpdated
Boehringer Ingelheim posts Brightline-2 brigimadlin results; BI 4060107 trial recruitsOct 15Weekly roundup, 5 itemsBoehringer Ingelheimempagliflozin
AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
Pfizer wins Xeljanz label update; registers four new trials across RSV, eczema, sleep apneaSep 16Weekly roundup, 7 itemsabrocitinibberobenatide
Teva gets FDA approval for generic tofacitinib citrate ER; two Claravis labeling supplements clearedAug 21Weekly roundup, 3 itemsTeva Pharmaceutical Industries Ltdtofacitinib
Pfizer wins five FDA label updates for tofacitinib, ritlecitinib, abrocitinib; Crohn's trial haltedJul 2Weekly roundup, 12 itemsabrocitinibatirmociclib